Refined By:
Date Issued:  [2010 TO 2019]
Date Issued:  2018

Results 1-7 of 7 (Search time: 0.002 seconds).

Issue DateTitleAuthor(s)
1201812-oxo chenodeoxycholic acid potentiates doxorubicin-induced oxidative stress through Nrf2 axis in breast adenocarcinoma cellsBojan Stanimirov ; Karmen Stankov ; Nebojša Pavlović ; Maja Đanić ; Jasmina Katanić ; Iva Barjaktarović ; Momir Mikov 
22018Bile acid potentiates apoptosis of human breast adenocarcinoma cells induced by doxorubicinBojan Stanimirov ; Karmen Stankov ; Nebojša Pavlović ; Maja Đanić ; Bogdanović G; Vesna Kojić ; Momir Mikov 
38-Nov-2018Bile acids and their derivatives as potential modifiers of drug release and pharmacokinetic profilesNebojša Pavlović ; Svetlana Goločorbin-Kon ; Maja Đanić ; Bojan Stanimirov ; Hani Al-Salami; Karmen Stankov ; Momir Mikov 
42018In vivo effects of ursodeoxycholic acid on doxorubicin-induced oxidative injury of hepatocyteBojan Stanimirov ; Karmen Stankov ; Nebojša Pavlović ; Maja Đanić ; Svetlana Goločorbin-Kon ; Momir Mikov 
52018Non-toxic bile acids as pharmaceutical excipients may alter pharmacological activity of antitumor drug vorinostatNebojša Pavlović ; Karmen Stankov ; Svetlana Goločorbin-Kon ; Mladena Lalić-Popović ; Bojan Stanimirov ; Maja Đanić ; Momir Mikov 
61-Jan-2018Pharmacological applications of bile acids and their derivatives in the treatment of metabolic syndromeMaja Đanić ; Bojan Stanimirov ; Nebojša Pavlović ; Svetlana Goločorbin-Kon ; Hani Al-Salami; Karmen Stankov ; Momir Mikov 
71-Jun-2018Potential Applications of Gliclazide in Treating Type 1 Diabetes Mellitus: Formulation with Bile Acids and ProbioticsMomir Mikov ; Maja Đanić ; Nebojša Pavlović ; Bojan Stanimirov ; Svetlana Goločorbin-Kon ; Karmen Stankov ; Hani Al-Salami